GRHL2 and cancer: As user-defined regions of interest, we selected 10,000 binding sites of LYL1, a transcription factor (TF) associated with hematopoietic cells [34], and GRHL2, an important pioneer TF for epithelial cells [35–37] playing a role in a wide variety of cancer types [38–42].